The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China

ABSTRACT Group B Streptococcus (GBS) is a leading pathogen responsible for fatal infections in newborns primarily due to vertical transmission from colonized mothers. Cases of invasive GBS infections in adults have also increased and attracted attention recently. To comprehensively understand the ev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingxing Li, Wenhang Yang, Yi Li, Kexin Hua, Ying Zhao, Taie Wang, Lingli Liu, Yali Liu, Yao Wang, Wenjing Liu, Li Zhang, Renyuan Zhu, Shuying Yu, Hongli Sun, Hongtao Dou, Qiwen Yang, Yingchun Xu, Lina Guo
Format: Article
Language:English
Published: American Society for Microbiology 2025-01-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02266-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556065231044608
author Yingxing Li
Wenhang Yang
Yi Li
Kexin Hua
Ying Zhao
Taie Wang
Lingli Liu
Yali Liu
Yao Wang
Wenjing Liu
Li Zhang
Renyuan Zhu
Shuying Yu
Hongli Sun
Hongtao Dou
Qiwen Yang
Yingchun Xu
Lina Guo
author_facet Yingxing Li
Wenhang Yang
Yi Li
Kexin Hua
Ying Zhao
Taie Wang
Lingli Liu
Yali Liu
Yao Wang
Wenjing Liu
Li Zhang
Renyuan Zhu
Shuying Yu
Hongli Sun
Hongtao Dou
Qiwen Yang
Yingchun Xu
Lina Guo
author_sort Yingxing Li
collection DOAJ
description ABSTRACT Group B Streptococcus (GBS) is a leading pathogen responsible for fatal infections in newborns primarily due to vertical transmission from colonized mothers. Cases of invasive GBS infections in adults have also increased and attracted attention recently. To comprehensively understand the evolving burden of vaginal GBS carriage in pregnant and non-pregnant women, as well as the trends in invasive GBS diseases and antibiotic resistance in China, we conducted a retrospective study using data from a large tertiary hospital in Beijing from 2013 to 2023. Over the past decade, improvements in GBS screening methods for pregnant women have significantly increased the GBS recovery rate. The detection rate of GBS and its proportion among vaginal pathogens have shown a gradual increase in GBS colonization in both pregnant and non-pregnant women. An analysis of vaginal pathogen composition revealed variations in GBS prevalence across different age groups, as well as a potential competitive relationship between GBS and Enterococcus faecalis in the vaginal environment. Additionally, we analyzed 165 invasive GBS cases, including three in newborns. The incidence of invasive GBS cases has risen since 2016, particularly among individuals over the age of 40. The 5,858 GBS isolates exhibited notably high resistance rates to erythromycin (72.2%), clindamycin (60%), and levofloxacin (50.1%), with 30.8% classified as multidrug-resistant. Importantly, invasive GBS strains exhibited a higher resistance rate to levofloxacin (61.2%) compared to colonizing strains (49.8%). This study highlights the importance of continuous screening and monitoring for GBS, especially given the concerning antibiotic resistance rates of GBS.IMPORTANCEGroup B Streptococcus (GBS) is an important pathogen that commonly causes infections in newborns and the elderly. This retrospective study provides a comprehensive analysis of GBS strains isolated from a large tertiary hospital in Beijing between 2013 and 2023, revealing an increasing colonization rate of GBS in both pregnant and non-pregnant women. Analysis of vaginal pathogens indicates a growing proportion of GBS among vaginal pathogens. Additionally, the high resistance rates of GBS to erythromycin, clindamycin, and levofloxacin, as well as the prevalence of multidrug resistance, are issues that merit attention. We also examined the differences in resistance rates of GBS strains from various sample types, finding that the levofloxacin resistance rate in GBS strains causing invasive infections was significantly higher than in colonizing strains. This study provides new data and insights for clinical research on GBS.
format Article
id doaj-art-031c7947168a4993893a9b1995c401d7
institution Kabale University
issn 2165-0497
language English
publishDate 2025-01-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-031c7947168a4993893a9b1995c401d72025-01-07T14:05:19ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-01-0113110.1128/spectrum.02266-24The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, ChinaYingxing Li0Wenhang Yang1Yi Li2Kexin Hua3Ying Zhao4Taie Wang5Lingli Liu6Yali Liu7Yao Wang8Wenjing Liu9Li Zhang10Renyuan Zhu11Shuying Yu12Hongli Sun13Hongtao Dou14Qiwen Yang15Yingchun Xu16Lina Guo17Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaABSTRACT Group B Streptococcus (GBS) is a leading pathogen responsible for fatal infections in newborns primarily due to vertical transmission from colonized mothers. Cases of invasive GBS infections in adults have also increased and attracted attention recently. To comprehensively understand the evolving burden of vaginal GBS carriage in pregnant and non-pregnant women, as well as the trends in invasive GBS diseases and antibiotic resistance in China, we conducted a retrospective study using data from a large tertiary hospital in Beijing from 2013 to 2023. Over the past decade, improvements in GBS screening methods for pregnant women have significantly increased the GBS recovery rate. The detection rate of GBS and its proportion among vaginal pathogens have shown a gradual increase in GBS colonization in both pregnant and non-pregnant women. An analysis of vaginal pathogen composition revealed variations in GBS prevalence across different age groups, as well as a potential competitive relationship between GBS and Enterococcus faecalis in the vaginal environment. Additionally, we analyzed 165 invasive GBS cases, including three in newborns. The incidence of invasive GBS cases has risen since 2016, particularly among individuals over the age of 40. The 5,858 GBS isolates exhibited notably high resistance rates to erythromycin (72.2%), clindamycin (60%), and levofloxacin (50.1%), with 30.8% classified as multidrug-resistant. Importantly, invasive GBS strains exhibited a higher resistance rate to levofloxacin (61.2%) compared to colonizing strains (49.8%). This study highlights the importance of continuous screening and monitoring for GBS, especially given the concerning antibiotic resistance rates of GBS.IMPORTANCEGroup B Streptococcus (GBS) is an important pathogen that commonly causes infections in newborns and the elderly. This retrospective study provides a comprehensive analysis of GBS strains isolated from a large tertiary hospital in Beijing between 2013 and 2023, revealing an increasing colonization rate of GBS in both pregnant and non-pregnant women. Analysis of vaginal pathogens indicates a growing proportion of GBS among vaginal pathogens. Additionally, the high resistance rates of GBS to erythromycin, clindamycin, and levofloxacin, as well as the prevalence of multidrug resistance, are issues that merit attention. We also examined the differences in resistance rates of GBS strains from various sample types, finding that the levofloxacin resistance rate in GBS strains causing invasive infections was significantly higher than in colonizing strains. This study provides new data and insights for clinical research on GBS.https://journals.asm.org/doi/10.1128/spectrum.02266-24group B Streptococcusvaginal GBS carriageinvasive GBS infectionantibiotic resistance
spellingShingle Yingxing Li
Wenhang Yang
Yi Li
Kexin Hua
Ying Zhao
Taie Wang
Lingli Liu
Yali Liu
Yao Wang
Wenjing Liu
Li Zhang
Renyuan Zhu
Shuying Yu
Hongli Sun
Hongtao Dou
Qiwen Yang
Yingchun Xu
Lina Guo
The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
Microbiology Spectrum
group B Streptococcus
vaginal GBS carriage
invasive GBS infection
antibiotic resistance
title The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
title_full The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
title_fullStr The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
title_full_unstemmed The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
title_short The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
title_sort increasing burden of group b streptococcus from 2013 to 2023 a retrospective cohort study in beijing china
topic group B Streptococcus
vaginal GBS carriage
invasive GBS infection
antibiotic resistance
url https://journals.asm.org/doi/10.1128/spectrum.02266-24
work_keys_str_mv AT yingxingli theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT wenhangyang theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yili theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT kexinhua theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yingzhao theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT taiewang theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT lingliliu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yaliliu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yaowang theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT wenjingliu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT lizhang theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT renyuanzhu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT shuyingyu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT honglisun theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT hongtaodou theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT qiwenyang theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yingchunxu theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT linaguo theincreasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yingxingli increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT wenhangyang increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yili increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT kexinhua increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yingzhao increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT taiewang increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT lingliliu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yaliliu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yaowang increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT wenjingliu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT lizhang increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT renyuanzhu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT shuyingyu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT honglisun increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT hongtaodou increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT qiwenyang increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT yingchunxu increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina
AT linaguo increasingburdenofgroupbstreptococcusfrom2013to2023aretrospectivecohortstudyinbeijingchina